Showing results (101-110 of 177) with videos related to
Sort By:
Pageof 18
Neurochemistry International|June 23, 2011
Aroclor1254 interferes with estrogen receptor-mediated neuroprotection against beta-amyloid toxicity in cholinergic SN56 cellsYeojin Bang, Juhee Lim, Sa Suk Kim, et al.Neuro-Oncology|July 11, 2014
Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cellsSeung Wook Kim, Hyun Jin Choi, Ho-Jeong Lee, et al.Archives of Pharmacal Research|February 19, 2008
Application of coupling reaction between lithiated toluamide and benzonitrile for the synthesis of phenolic benzo[c]phenanthridine alkaloid, oxyterihanineNguyen Le Thanh, Hue Thi My Van, Suh-Hee Lee, et al.The Journal of Organic Chemistry|October 13, 2020
Collective Syntheses of Guaiane Sesquiterpenes: Stereoselective Syntheses of (+)-Dysodensiol F, (+)-10β,14-Dihydroxy-allo-aromadendrane, and (-)-Dendroside C AglyconHyun Su Kim, Hyunkyung Park, Juhee Lim, et al.International Journal of Nanomedicine|May 18, 2026
Precision Engineering of Extracellular Vesicles as Programmable Carriers for mRNA TherapeuticsHyejoo Yoon, Gyuwon Lee, Junyeong Jo, et al.Cancers|December 23, 2023
Adverse Effect of the Duration of Antibiotic Use Prior to Immune Checkpoint Inhibitors on the Overall Survival of Patients with Recurrent Gynecologic MalignanciesHye-Ji Jung, Jong-Ho Park, Jina Oh, et al.Biochemical and Biophysical Research Communications|August 30, 2008
Acetylation of Sirt2 by p300 attenuates its deacetylase activityYounho Han, Yun-Hye Jin, Yeon-Jin Kim, et al.Kidney Research and Clinical Practice|January 9, 2019
Acute kidney injury in childhood-onset nephrotic syndrome: Incidence and risk factors in hospitalized patientsMi Young Kim, Myung Hyun Cho, Ji Hyun Kim, et al.Molecular and Cellular Neurosciences|September 30, 2010
Transcription factor AP-2β regulates the neurotransmitter phenotype and maturation of chromaffin cellsSeok Jong Hong, Yang Hoon Huh, Amanda Leung, et al.Current Problems in Cancer|February 19, 2020
Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancerHyun-Jin Choi, Yoo-Young Lee, Chel Hun Choi, et al.Pageof 18